Filter
204
Filtered Results: 204
Text search:
myocarditis
Featured
Recommendations
30
New Publications
59
Language
Document type
Guidelines
82
No document type
74
Studies & Reports
23
Manuals
12
Fact sheets
11
Training Material
1
Resource Platforms
1
Countries / Regions
India
14
Latin America and the Carribbean
10
Argentina
10
Brazil
8
Global
6
Venezuela
6
Paraguay
6
Indonesia
6
Colombia
5
Germany
5
Rwanda
4
South Africa
4
Bolivia
3
Ecuador
3
El Salvador
2
Philippines
2
Mozambique
2
USA
2
Africa
2
Tanzania
2
West and Central Africa
2
Western and Central Europe
2
Bangladesh
2
Nepal
1
Kenya
1
Ukraine
1
Lesotho
1
Ghana
1
Sierra Leone
1
Chile
1
Nigeria
1
Peru
1
Zimbabwe
1
Congo, Democratic Republic of
1
Western Pacific Region
1
East and Southern Africa
1
Uganda
1
Nicaragua
1
Russia
1
Ethiopia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
64
COVID-19
34
Studies & Reports
12
Chagas
8
Clinical Guidelines
6
NTDs & Others
6
Pediatrics
5
Vaccine-preventable Diseases
5
Drugs & Medical Equipment
5
Women & Child Health
5
Communicable Diseases
4
Paediatrics
4
Dermatology
4
Capacity Building
4
Immunization
4
Communicable Diseases
4
Dengue
4
HIV & STI
4
Disease Prevention & Control
4
Policies & Guidelines HIV & TB
3
Surgery & Anaesthesia
3
Dental & Eye Care
2
Child Health
2
Vector Control
2
Cardiovascular Diseases
2
Yellow Fever
2
Zika
1
Under-5 nutrition
1
Diabetes
1
Bacteriology
1
Humanitarian Aid
1
MPOX - Monkeypox
1
Maternal & Child Health
1
NCD
1
Hemorrhagic Fever
1
Policies
1
Statistics
1
General Guidelines
1
Gynaecology & Obstetrics
1
Key Resources
1
Toolboxes
Country specific documents
26
Long COVID/ Post-COVID Syndrome
13
Clinical Guidelines
11
Immunization Guidelines
7
Biontech/Pfizer Comirnaty
7
Moderna
6
Studies & Reports
5
Dengue
4
Inactivated COVID-19 Vaccines
4
Chagas
4
Surveillance
3
Paediatrics
3
Johnson & Johnson
3
Handbooks & Manuals
3
Overview, Studies & Reports
3
Substance Use Disorders & Addiction
3
Alcohol
2
Yellow Fever
2
Vaccination
2
Context & Facts, Travel Advice
2
Scientific & Research Studies
2
Communication Material
2
COVID-19 Vaccination
2
COVID-19 Vaccination Information
2
Booster Doses
2
Model Formulary
2
Mental Disorders
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Information & Education Material (IEC)
2
Chikungunya
2
Assessment & Studies
1
Meningitis Prevention & Control
1
Laboratory Guidance
1
Clinical Aspects, Treatment & Prevention
1
Treatment & Prevention
1
Clinical Aspects
1
Country specific
1
Influenza Prevention & Control
1
Diagnosis & Treatment PTSD in Children
1
Substance Use Disorders, Others
1
Influenza
1
Context, Facts & Travel Advice
1
Opoids
1
Stroke
1
Public Health
1
Laboratory & Sampling
1
Clinical Guidelines
1
Clinical Aspects
1
Diagnostics & Laboratory Guidance
1
Country Specific
1
Oxygen Therapy
1
Essential Medicines & Medical Devices
1
Blood Supply
1
Long-term Care Facilities
1
Logistics & Supply
1
mRna Vaccines general
1
Others
1
Reports & Studies
1
Guidelines & Manuals
1
Zoonoses
1
MPOX - Monkeypox
1
NTDs
1
Dengue & Chikungunya
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
NTDs General
1
Vector control
1
Leptospirosis
1
Co-Morbidities (except TB)
1
Neurological Disorders
1
Bipolar Affective Disorders
1
Prophylactic Treatment
1
Education of students & professionals
1
Self-harm & Suicide
1
Germany
1
Dengue Prevention & Control
1
Latin America & the Carribean
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Anxiety Disorders
1
Antiretroviral Treatment ART
1
Depression
1
Case Definitions
1
Volunteers
1
Reports & Studies
1
Vaccination
1
short information on flu and the annual vaccination for people of age 60+ in germany
also available in german, turkish, russian, arabic on
https://www.bzga.de/infomaterialien/impfungen-und-persoenlicher-infektionsschutz/grippeimpfung/grippeimpfung-der-richtige-schritt-fuer-einen-sicheren-schutz/...
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3026 (Published 11 August 2020)
The BMJ "practice pointer" inlcudes a one-page visual summary of assessment and initial management of patients with persistant symptoms following acute SARS-CoV-2 infection
Dispõe sobre orientações para identificação, investigação e manejo do evento adverso pós vacinação de miocardite/pericardite no contexto da vacinação contra a COVID-19 no Brasil
Existen notificaciones de eventos relacionados con la vacuna (ESAVI) de
miocarditis/pericarditis en adolescentes tras la administración de vacunas ARNm(Pfizer y Moderna) especialmente tras la segunda dosis. Al momento no seencuentra asociación entre la enfermedad y la administración de la vacuna...
La miocarditis es una enfermedad inflamatoria con compromiso focal o difuso del miocardio, que se presenta de forma fulminante, pudiendo ser aguda, subaguda o crónica.Las que poseen un nivel de gravedad suficiente para reconocerlas clínicamente, son raras, pero la prevalencia de los casos leves y ...
Campaña Nacional de Vacunación contra la COVID-19
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de...
Background: East African trypanosomiasis is an uncommon, potentially lethal disease if not diagnosed and treated in a timely manner. South Africa, as a centre for emergency medical evacuations from much of sub-Saharan Africa, receives a high proportion of these patients, mostly tourists and expatria...
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type of diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristicall...
